Can there possibly be good buying in single-digit share prices? I’ve been trawling through the ASX-listed population looking for this kind of situation, and here are two single-digit share prices that I think fit the bill
The fact of biotech investing is that the share prices are at the mercy of news flow from drug trial results, partnerships with bigger companies, regulatory interactions and a wide range of other events that can point to the increased – or decreased – likelihood of the drug, medical device or diagnostic test ever reaching the market.
There’s no shortage of world-class innovation coming out of our neighbour across the ditch. Here are three Kiwi stocks that I think are global standouts in their fields — and each of these, for various reasons, looks to be alluringly cheap right now.
Here are three of the best (non-Kiwi) foreign listings: Block (Afterpay), Resmed and Zimplats.
Here’s a look at 4 of the solid- material recycling stocks that I see as leading the way in the “circular economy.”
Takeovers aren’t easy to predict, but here are four situations where I think an acquisitive move wouldn’t be at all surprising.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.